Navigation Links
Meet TerViva, an Emerging Star in Sustainable Biofuels
Date:11/22/2013

New York, NY (PRWEB) November 22, 2013

TerViva, a start-up based in Oakland, California, is changing the face of agriculture and aims to diversify and sustain the world’s agriculture one crop at a time. Working within the $121B biofuels market, TerViva is taking its first stab at commercial-level agriculture with its new legume crop, Pongamia.

Pongamia is a hardy plant that is able to withstand harsh conditions such as soil salinity and low water levels, which would be impossible for other plants. With 20 times as many gallons per acre than corn, Pongamia can drop-in to existing agricultural infrastructure and provides biofuel and protein-rich seedcake that may be used for animal feed. Not to mention, Pongamia grows on land that does not compete for food.

As the world’s food and supply demand increases while farmland is reduced, a solution for land deemed “unusable farmland” must be found. TerViva is well on its way to doing just that. The key to sustainable agriculture is bringing more biodiversity to already existing infrastructure, according to TerViva. With just 7 crops dominating the U.S. agriculture scene, TerViva wants to encourage a variety of species.

Working with some big partners, including US Sugar Corp and Mosaic, some of ag’s biggest leaders are firm believers of TerViva’s work and potential. Just recently, TerViva signed with one of the largest agriculture operators in the country to produce Pongamia on 10,000 acres.

And with TerViva’s team credentials, it’s no wonder they’re grabbing the attention of some of the largest ag companies in the U.S. TerViva’s cofounders and investors include Joseph Andrew, former Chairman of the Democratic National Party, his wife Ann Slaughter Andrew an environmental attorney and the former Ambassador to Costa Rica, and CEO Naveen Sikka who served on the steering committee for Cleantech for Obama. TerViva has also been featured in numerous biofuels tra
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Genelux, a Leader in the Emerging Oncolytic Virotherapy Field, Receives Significant Industry Honor from Elsevier Business Intelligence, Identifying GL-ONC1 as One of 2013s Top Oncology Projects to Watch
2. PAREXEL International To Present At Goldman Sachs Emerging Growth Conference
3. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
4. Market Briefing: Emerging Growth NASDAQ Stocks in the News
5. Interventional Cardiology Devices - Emerging Markets 2009-2015
6. Green future development: Top 10 priorities for emerging economy countries
7. Emerging Global Leader in Emergency Thermotherapy for Traumatic Brain Injury Expands US Operations to Site on the Campus of New York Medical College
8. Next Generation Sequencing: Emerging Clinical Applications and Global Markets
9. Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
10. PrimeraDx Featured in the Goldman Sachs Healthcare Research Teams GS Emerging Healthcare Series
11. Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... DUBLIN , Feb. 27, 2015 Research and Markets ... the "Global Market Report of Trypsin" report to ... Trypsin (CAS 9002-07-7) aims at providing comprehensive data on Trypsin ... Asia , North America , ... trends, pays close attention to Trypsin This report ...
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)... San Francisco, CA (PRWEB) February 27, 2015 ... is joining forces on February 28 with patients and ... to raise awareness for Rare Disease Day®. Rare ... rare diseases and calling attention to the special challenges ... community around them. , “Cytokinetics is proud to stand ...
(Date:2/26/2015)... 2015 S&P Capital IQ (MHFI) announced today ... on MabVax Therapeutics Holdings Inc . ... biotechnology company focused on the development of vaccine and ... treatment of cancer. MabVax has discovered a pipeline of ... responses generated by patients who have been immunized against ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5
... NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today announced that ... SL-501, in both in vitro and animal models of ... at the upcoming 51st Annual Meeting of the American Society of ... 2009. The poster will be presented by Stemline,s collaborators at The ...
... MELVILLE, N.Y., Dec. 3 Nikon Corporation, an innovator ... signed a licensing agreement with Harvard University granting Nikon ... (STORM) technology. Under the terms of the agreement, Nikon ... with the N-STORM name. , Nikon Corporation President, ...
... , PHILADELPHIA, Dec. 3 Shire plc ... company, today announced a voluntary recall of five lots and ... (ADHD) patch Daytrana ® . Shire is taking this action ... future may not meet their release liner removal specification, and ...
Cached Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
(Date:2/10/2015)... Feb. 10, 2015  Alere Inc. (NYSE: ALR), ... financial results for the quarter ended December 31, ... and President of Alere said, "We made substantial ... as the global leader in rapid diagnostics and ... Alere Health divestiture in early January enabled us ...
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... unusual regulatory mechanism that controls the swimmer/non-swimmer option in ... ability to cause infection. University of Washington scientists ... of the National Academy of Sciences. As ... of the two forms of the bacteria can emerge. ...
... Dec. 8, 2011 Reportlinker.com announces that ... in its catalogue: Global ... This report analyzes the ... US$ by the following Technologies: AFIS (Automated ...
... at the Salk Institute for Biological Studies have developed a ... cell disease and many other disorders caused by mutations in ... uses cells from a patient,s skin to generate induced pluripotent ... types of mature tissues -- including blood. The scientists say ...
Cached Biology News:How Salmonella forms evil twins to evade the body's defenses 2How Salmonella forms evil twins to evade the body's defenses 3Global Biometrics Industry 2Global Biometrics Industry 3Global Biometrics Industry 4Global Biometrics Industry 5Global Biometrics Industry 6Global Biometrics Industry 7Global Biometrics Industry 8Global Biometrics Industry 9Global Biometrics Industry 10Global Biometrics Industry 11Global Biometrics Industry 12Global Biometrics Industry 13Global Biometrics Industry 14Global Biometrics Industry 15Global Biometrics Industry 16Global Biometrics Industry 17Global Biometrics Industry 18Global Biometrics Industry 19Global Biometrics Industry 20Global Biometrics Industry 21Global Biometrics Industry 22Global Biometrics Industry 23Global Biometrics Industry 24Salk researchers develop safe way to repair sickle cell disease genes 2Salk researchers develop safe way to repair sickle cell disease genes 3Salk researchers develop safe way to repair sickle cell disease genes 4
... PROTEAN II xi multi-cell is for 2-D separations. ... cooling capabilities. The PROTEAN II xi multi-cell can ... type of glass plates, and cooling system. The ... to the PROTEAN II XL multi-cell for a ...
F40 piston seals are supplied as 2 seals with a seal tool to service one F40 pump of a BioLogic DuoFlow workstation....
... probe for DNA. Binds to the minor ... rich DNA), forming a stable complex which ... alone. DAPI is several times more sensitive ... agarose gels. It may be used for ...
Mol wt: monoisotopic mol wt1,045.5423 Da by calculation...
Biology Products: